Pyruvate kinase deficiency is an inherited deficiency of the  enzyme   pyruvate kinase, which is used by red blood cells. Without this enzyme, red blood cells break down too easily, resulting in low levels of these cells ( hemolytic anemia  ).
                    
                 
                  
                 
                
                
               
               
                
                
                    
                        Causes, incidence, and risk factors
                    
                          Pyruvate kinase deficiency is transmitted as an  autosomal recessive   trait, which means that a child must get the defective gene from both parents to develop the disorder.  There are many different types of enzymatic defects of the red blood cell which can cause  hemolytic anemia  . Pyruvate kinase deficiency is the second most common cause of enzymatic-related hemolytic anemia. ( G-6-PD deficiency   is the number one cause.)  Pyruvate kinase deficiency may produce mild or severe  hemolysis   and  anemia  . Problems may first appear in the newborn as prolonged  jaundice   and anemia. Older children may be  pale   (due to anemia) and have intermittent episodes of jaundice. Occasionally, it is not discovered until adulthood in mild cases.  Although pyruvate kinase deficiency is found in people of all ethnic backgrounds, certain populations, such as the Amish, have a somewhat higher incidence.
                    
                 
                
                    
                        Signs and tests
                    
                          During a physical exam, the doctor will look for an  enlarged spleen  .  
Tests include the following: 
CBC    showing anemia with normocytic (not pale) red blood cells macrocytosis    (large red blood cells) pyruvate kinase    activity shows deficient levels of this   enzyme   in red blood cells  
 high levels of bilirubin in the blood    low levels of haptoglobin in the blood    increased   osmotic fragility   or red blood cells may not be present  
 high fecal urobilinogen    genetic testing for mutation in the pyruvate kinase gene 
                    
                 
                
                    
                        Treatment
                    
                                   Blood transfusions may be needed for severe  anemia  . Removal of the spleen ( splenectomy  ) may help to reduce the destruction of red blood cells; however, this should not necessarily be performed as it does not help in all cases. In newborns with dangerous levels of  jaundice  , an  exchange transfusion   is likely to be recommended.  If a splenectomy was done, the person should receive pneumococcal vaccine at recommended intervals.         
                    
                 
                
                
                    
                        Expectations (prognosis)
                    
                                   The outcome varies. Some people have few or no symptoms, others have severe symptoms. Treatment is usually successful in reducing the severity of symptoms.        
                    
                 
                
                    
                        Complications
                    
                                   Gallstones, composed of bilirubin produced in excess during hemolytic anemia, are a common problem. Severe pneumococcal disease following  splenectomy   is a possible complication.         
                    
                 
                
                    
                        Calling your health care provider
                    
                           See your health care provider if  jaundice   occurs at any time; this is a symptom of many severe illnesses.  
See your health care provider if you have a family history of this disorder and are planning a pregnancy.  
                    
                 
                
                    
                        Prevention
                    
                         Genetic counseling   is of value to prospective parents with a family history of pyruvate kinase deficiency. People who carry they gene can often be diagnosed by the presence of decreased RBC  pyruvate kinase   activity in their red blood cells.